EBIT (Annual)

EBIT: Income before interest and taxes.

Harmony Biosciences Holdings, Inc. (HRMY) had EBIT of $208.47M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$868.45M
Net Income	$158.69M
Cost of Goods Sold	$198.34M
Gross Profit	$670.11M
Operating Expenses	$659.98M
Operating Income	$208.47M
Non-Operating Income/Expense	$6.59M
Pre-Tax Income	$215.06M
Normalized Pre-Tax Income	$215.06M
Income after Taxes	$158.69M
Income from Continuous Operations	$158.69M
Consolidated Net Income/Loss	$158.69M
Normalized Income after Taxes	$158.69M
EBIT	$208.47M
EBITDA	$232.93M
Weighted-Average Shares Outstanding (Basic)	57.49M
Weighted-Average Shares Outstanding (Diluted)	58.54M
Earnings per Share (EPS) (Basic)	$2.76
Earnings per Share (EPS) (Diluted)	$2.71
Balance Sheet Financials
Current Assets	$907.01M
Property, Plant, and Equipment	--
Long-Term Assets	$364.62M
Total Assets	$1.27B
Current Liabilities	$252.13M
Long-Term Debt	$143.66M
Long-Term Liabilities	$149.28M
Total Liabilities	$401.41M
Common Equity	$870.22M
Tangible Shareholders Equity	$780.80M
Shareholders Equity	$870.22M
Common Shares Outstanding	57.73M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$348.20M
Cash Flow from Investing Activities	$-39.65M
Cash Flow from Financial Activities	$-9.05M
Beginning Cash	$453.27M
End Cash	$752.77M
Increase/Decrease in Cash	$299.50M
Stock-Based Compensation	$44.90M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.60
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.14
Debt to Equity Ratio	0.19
Gross Margin	77.16%
Operating Margin	24.00%
EBIT Margin	24.00%
EBITDA Margin	26.82%
Pre-Tax Profit Margin	24.76%
Profit Margin	18.27%
Free Cash Flow	$347.89M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.68
Inventory Turnover	37.02
Receiveable Turnover	8.97
Days Sales in Receivables	40.68
Return on Equity	18.24%
Return on Tangible Equity	20.32%
Return on Assets	12.48%
Return on Investments	15.65%
Book Value Per Share	$15.07
Free Cash Flow per Share	$5.94
Operating Cash Flow per Share	$5.95

Data from Zacks Investment Research, Inc.